125 related articles for article (PubMed ID: 38527834)
1. [Clinical features and risk factors for invasive fungal sinusitis after allogeneic hematopoietic stem cell transplantation].
Fu HX; Li JJ; Zhang YY; Sun YQ; Mo XD; Han TT; Kong J; Lyu M; Han W; Chen H; Chen YY; Wang FR; Yan CH; Chen Y; Wang JZ; Wang Y; Xu LP; Huang XJ; Zhang XH
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):22-27. PubMed ID: 38527834
[No Abstract] [Full Text] [Related]
2. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
Pepeler MS; Yildiz Ş; Yegin ZA; Özkurt ZN; Tunçcan ÖG; Erbaş G; Köktürk N; Kalkanci A; Yildirim Z
J Infect Dev Ctries; 2018 Sep; 12(9):799-805. PubMed ID: 31999640
[TBL] [Abstract][Full Text] [Related]
3. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
[TBL] [Abstract][Full Text] [Related]
4. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
[TBL] [Abstract][Full Text] [Related]
5. [A clinical analysis of micafungin treatment of pulmonary invasive fungal infection in pediatric patients with acute leukemia or post hematopoietic stem cells transplantation].
Huang K; Qiu KY; Deng LL; Fang JP; Li Y; Guo HX; Zhou DH
Zhonghua Er Ke Za Zhi; 2017 Nov; 55(11):844-847. PubMed ID: 29141316
[No Abstract] [Full Text] [Related]
6. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
[TBL] [Abstract][Full Text] [Related]
7. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Busca A; Candoni A; Audisio E; Passera R; Bruno B; Monaco F; Mordini N; Vacca A; Delia M; Aversa F; Pagano L
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012
[TBL] [Abstract][Full Text] [Related]
8. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH
Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662
[TBL] [Abstract][Full Text] [Related]
9. [The effect of glucose-6-phosphate dehydrogenase deficiency on allogeneic hematopoietic stem cell transplantation in patients with hematological disorders].
Wang J; Fu HX; Zhang YY; Mo XD; Han TT; Kong J; Sun YQ; Lyu M; Han W; Chen H; Chen YY; Wang FR; Yan CH; Chen Y; Wang JZ; Wang Y; Xu LP; Huang XJ; Zhang XH
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):121-127. PubMed ID: 38604787
[No Abstract] [Full Text] [Related]
10. Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study.
Ye P; Pei R; Hu Y; Chen D; Li S; Cao J; Li F; Wu M; Fang Y; Lu Y
BMC Infect Dis; 2022 May; 22(1):465. PubMed ID: 35570276
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for T lymphoblastic leukemia/lymphoma].
Luo L; Jiao Y; Yang P; Li Y; Huang WY; Ke XY; Zou DH; Jing HM
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):388-394. PubMed ID: 37550188
[No Abstract] [Full Text] [Related]
12. [Clinical features and risk factors of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation].
Wu Q; Zhou F; Song NX; Liu XM; Yu Z; Song XC; Li X; Zhang H
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):187-190. PubMed ID: 30929383
[No Abstract] [Full Text] [Related]
13. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2021; 12():605766. PubMed ID: 34025637
[TBL] [Abstract][Full Text] [Related]
14. Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
Chien SH; Liu YC; Liu CJ; Ko PS; Wang HY; Hsiao LT; Chiou TJ; Liu JH; Gau JP
J Microbiol Immunol Infect; 2019 Dec; 52(6):973-982. PubMed ID: 30322746
[TBL] [Abstract][Full Text] [Related]
15. Successful allogeneic stem cell transplantation in a case with acute myeloid leukemia and invasive Schizophyllum commune rhinosinusitis.
Harada T; Kuriyama T; Nishida R; Yoshimoto G; Mori Y; Imanaga H; Ueno T; Odawara J; Hayashi M; Kato K; Takenaka K; Akashi K; Miyamoto T
J Infect Chemother; 2020 May; 26(5):506-509. PubMed ID: 32146107
[TBL] [Abstract][Full Text] [Related]
16. Surgical debridement for acute invasive fungal rhinosinusitis during the pre-engraftment phase of allogeneic hematopoietic stem cell transplantation: Two case reports.
Cheng HY; Yuan L; Wang JB
Medicine (Baltimore); 2018 Oct; 97(42):e12696. PubMed ID: 30334953
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 14 patients aged ≤ 50 years with high-risk multiple myeloma treated with allogeneic hematopoietic stem cell transplantation].
Pan P; Wang JL; Zhai WH; Ma QL; Yang DL; Feng SZ; Han MZ; Pang AM; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):28-34. PubMed ID: 38527835
[No Abstract] [Full Text] [Related]
18. Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy.
Chen W; Ma Y; Shen Z; Chen H; Ma R; Yan D; Shi M; Wang X; Song X; Sun C; Cao J; Cheng H; Zhu F; Sun H; Li D; Li Z; Zheng J; Xu K; Sang W
Front Immunol; 2021; 12():755549. PubMed ID: 34777367
[TBL] [Abstract][Full Text] [Related]
19. Perianal Infections in the Phase before Engraftment after Allogeneic Hematopoietic Stem Cell Transplantations: A Study of the Incidence, Risk Factors, and Clinical Outcomes.
Mo XD; Yan X; Hu W; Zhang XH; Xu LP; Wang Y; Xu XD; Wang LN; He XX; Yan CH; Chen H; Chen YH; Liu KY; Huang XJ
Acta Haematol; 2018; 139(1):19-27. PubMed ID: 29320771
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
